|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|NVIV||InVivo Therapeutics Hldg||0.66||0.00||-0.7%||22.5M|
You can purchase shares of InVivo Therapeutics Hldg (NASDAQ: NVIV) through any online brokerage.
The latest price target for InVivo Therapeutics Hldg (NASDAQ: NVIV) was reported by Raymond James on May 5, 2017. The analyst firm set a price target for 0.00 expecting NVIV to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for InVivo Therapeutics Hldg (NASDAQ: NVIV) is $0.6558 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for InVivo Therapeutics Hldg.
There is no upcoming split for InVivo Therapeutics Hldg.
InVivo Therapeutics Hldg is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.